Boston Scientific Corporation
Officials from Boston Scientific Corporation report on recent developments
Published in Surgery Litigation and Law Weekly, May 11th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Boston Scientific Corporation.
Report 1: Boston Scientific Corporation (NYSE:BSX) announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS(R) Express2(TM) paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis - the regrowth of diseased tissue into a previously stented artery utilizing bare-metal stents - compared to vascular brachytherapy. The Company made the announcement at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Depression
Reports from University of Nijmegen, Department of Geriatrics advance knowledge in depression - Financing
Symbion, Inc. Agrees to Be Acquired by Crestview Partners Affiliate for $22.35 Per Share in Cash - Patents
Novadaq acquires portfolio of fluorescence endoscopy patents from Xillix - STAAR Surgical Company
STAAR Surgical Announces Pricing of Common Stock Offering - Symbion, Inc.
Symbion, Inc. Announces First Quarter 2007 Results - Abdominal Aortic Aneurysm Epidemiology
Data on abdominal aortic aneurysm epidemiology detailed by researchers at St. George's Hospital - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
